§ 522.2065. Rabacfosadine.
94 words·~1 min read·
/us/cfr/t21/s§ 522.2065A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
(a)Specifications. Each vial of powder contains 16.4 milligrams
(mg)rabacfosadine. Each milliliter of constituted solution contains 8.2 mg rabacfosadine.
(b)Sponsor. See No. 058198 in § 510.600(c) of this chapter.
(c)Conditions of use in dogs—(1) Amount. Administer rabacfosadine at 1 mg/kilogram body weight as a 30-minute intravenous infusion, once every 3 weeks, for up to 5 doses.
(2)Indications for use. For the treatment of lymphoma in dogs.
(3)Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian. [87 FR 10969, Feb. 28, 2022]
Connections1 cite this
Cited by 1 section
Citation graph
cites case law
§ 522.2065
Rabacfosadine.
Fed. Reg.×1
Cites 0Cited by 1 across 1 source